dˈʊɹɹɪŋ ðə tˈɛnθ kˈɑːnfɹəns ˌɔn ɹˌɛtɹoʊvˈaɪɹəsᵻz ænd ɑːpɚtuːnˈɪstɪk ɪnfˈɛkʃənz ɪn bˈɔstən, lˈændʒ ɐnˈaʊnst ðə ɹɪzˈʌlts əvə lˈɑːɹdʒ mˌʌltɪsˈɛntɚ klˈɪnɪkəl tɹˈaɪəl wɪððɪ ɪnvˈɑːlvmənt ʌv wˈʌn,tˈuːhˈʌndɹɪd sˈɪkstiːn pˈeɪʃənts ɪn sˈɛvəntˌiːn kˈʌntɹiz.
During the 10th Conference on Retroviruses and Opportunistic Infections in Boston, Lange announced the results of a large multicenter clinical trial with the involvement of 1,216 patients in 17 countries.